Skip to content

Fulgent Genetics, Inc. FLGT Other Non-Current Liabilities

Other Non-Current Liabilities at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$4.85B+8.4%
Myriad Genetics logo
Myriad GeneticsMYGN
$1.7M-15.0%
Labcorp Holdings logo
Labcorp HoldingsLH
$691.8M+38.9%
Quest Diagnostics logo
Quest DiagnosticsDGX
$1.02B+11.5%
NeoGenomics logo
NeoGenomicsNEO
$12.03M+0.9%
Natera, Inc. logo
Natera, Inc.NTRA
$16.27M

Other financials

Income statement

See full
Revenue$71.1M-3.2%
Gross profit$21.5M-24.2%
Operating income-$34.6M-74.9%
Net income-$24.8M-115%
EPS (diluted)-$0.80-116%

Balance sheet

See full
Cash & equivalents$23.4M-65.2%
Total debt$8.2M+40.5%
Total equity$1.0B-6.9%
Total assets$1.2B-4.1%

Cash flow

See full
Operating cash flow$7.1M+260%
CapEx$5.2M+10.3%
Free cash flow$1.9M+121%

Valuation

See full
Market cap$552.11M-7.1%
Enterprise value$536.92M+0.7%
P/S1.7×-0.3×

Profitability

See full
Gross margin38.7%-0.1pp
Operating margin-33.1%+17.4pp
Net margin-23%+43.3pp
FCF margin-36.9%

Returns & leverage

See full
Return on equity-6.8%+48.2pp
Debt / equity0.0×
Current ratio5.3×-1.0×

Where this comes from

Reported directly by Fulgent Genetics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OtherLiabilitiesNoncurrent.

The official record: Fulgent Genetics, Inc.’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about Fulgent Genetics, Inc.'s other non-current liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Fulgent Genetics, Inc.'s other non-current liabilities?
Fulgent Genetics, Inc. (FLGT) reported other non-current liabilities of $9.37M in Q1 2026.
How has Fulgent Genetics, Inc.'s other non-current liabilities changed year-over-year?
Fulgent Genetics, Inc.'s other non-current liabilities increased by 53.1% year-over-year, from $6.12M to $9.37M.
What is the long-term trend for Fulgent Genetics, Inc.'s other non-current liabilities?
Over 5 years (2020 to 2025), Fulgent Genetics, Inc.'s other non-current liabilities has grown at a 67.3% compound annual growth rate (CAGR), from $582K to $7.62M.
What does other non-current liabilities mean?
Miscellaneous long-term obligations not classified in specific categories — pension liabilities, environmental remediation, and other long-term accruals.